This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Multicenter Study

. 2008 Mar;40(3):259-60; author reply 260-1.

doi: 10.1038/ng0308-259.

A promoter polymorphism in the CASP8 gene is not associated with cancer risk

Christopher A Haiman, Rachel R Garcia, Laurence N Kolonel, Brian E Henderson, Anna H Wu, Loïc Le Marchand

PMID: 18305469
DOI: 10.1038/ng0308-259

Free article

Multicenter Study

A promoter polymorphism in the CASP8 gene is not associated with cancer risk

Christopher A Haiman et al. Nat Genet. 2008 Mar.

Free article

. 2008 Mar;40(3):259-60; author reply 260-1.

doi: 10.1038/ng0308-259.

Authors

Christopher A Haiman, Rachel R Garcia, Laurence N Kolonel, Brian E Henderson, Anna H Wu, Loïc Le Marchand

PMID: 18305469
DOI: 10.1038/ng0308-259

No abstract available

PubMed Disclaimer

Comment on

A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.
Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C, Lin D. Sun T, et al. Nat Genet. 2007 May;39(5):605-13. doi: 10.1038/ng2030. Epub 2007 Apr 22. Nat Genet. 2007. PMID: 17450141

Similar articles

A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population.
Cybulski C, Wokołorczyk D, Gliniewicz B, Sikorski A, Górski B, Jakubowska A, Huzarski T, Byrski T, Debniak T, Gronwald J, Lubiński J, Narod SA. Cybulski C, et al. Breast Cancer Res Treat. 2008 Nov;112(2):367-8. doi: 10.1007/s10549-007-9864-5. Epub 2007 Dec 21. Breast Cancer Res Treat. 2008. PMID: 18097748 No abstract available.
Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer.
Kesarwani P, Mandal RK, Maheshwari R, Mittal RD. Kesarwani P, et al. BJU Int. 2011 Feb;107(3):471-6. doi: 10.1111/j.1464-410X.2010.09533.x. Epub 2010 Aug 27. BJU Int. 2011. PMID: 20804486
Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
De Vecchi G, Verderio P, Pizzamiglio S, Manoukian S, Barile M, Fortuzzi S, Ravagnani F, Pierotti MA, Radice P, Peterlongo P. De Vecchi G, et al. Breast Cancer Res Treat. 2009 Feb;113(3):607-8. doi: 10.1007/s10549-008-9963-y. Epub 2008 Mar 16. Breast Cancer Res Treat. 2009. PMID: 18343995 No abstract available.
Inherited susceptibility to common cancers.
Foulkes WD. Foulkes WD. N Engl J Med. 2008 Nov 13;359(20):2143-53. doi: 10.1056/NEJMra0802968. N Engl J Med. 2008. PMID: 19005198 Review. No abstract available.
IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
Quan H, Tang H, Fang L, Bi J, Liu Y, Li H. Quan H, et al. Cell Biochem Biophys. 2014 May;69(1):169-78. doi: 10.1007/s12013-013-9784-4. Cell Biochem Biophys. 2014. PMID: 24310658

See all similar articles

Cited by

Susceptibility loci associated with prostate cancer progression and mortality.
Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, Fine S, Reuter V, Scher HI, Halldén C, Dutra-Clarke A, Klein RJ, Scardino PT, Eastham JA, Lilja H, Kirchhoff T, Offit K. Gallagher DJ, et al. Clin Cancer Res. 2010 May 15;16(10):2819-32. doi: 10.1158/1078-0432.CCR-10-0028. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460480 Free PMC article.
Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer.
Liamarkopoulos E, Gazouli M, Aravantinos G, Tzanakis N, Theodoropoulos G, Rizos S, Nikiteas N. Liamarkopoulos E, et al. Gastric Cancer. 2011 Oct;14(4):317-21. doi: 10.1007/s10120-011-0045-1. Epub 2011 Apr 2. Gastric Cancer. 2011. PMID: 21461653
Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.
Lubahn J, Berndt SI, Jin CH, Klim A, Luly J, Wu WS, Isaacs S, Wiley K, Isaacs WB, Suarez BK, Hayes RB, Kibel AS. Lubahn J, et al. Prostate. 2010 May 1;70(6):646-53. doi: 10.1002/pros.21098. Prostate. 2010. PMID: 20033885 Free PMC article.
The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
Li C, Lu J, Liu Z, Wang LE, Zhao H, El-Naggar AK, Sturgis EM, Wei Q. Li C, et al. Cancer Prev Res (Phila). 2010 Feb;3(2):246-53. doi: 10.1158/1940-6207.CAPR-08-0228. Epub 2010 Jan 19. Cancer Prev Res (Phila). 2010. PMID: 20086182 Free PMC article.
CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men.
Fu G, Tang J, Wang M, Qin C, Yan F, Ding Q, Yin C, Wang X, Zhang Z. Fu G, et al. J Biomed Res. 2011 Mar;25(2):128-34. doi: 10.1016/S1674-8301(11)60016-X. J Biomed Res. 2011. PMID: 23554680 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- eScholarship, University of California - Access Free Full Text
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal